Robbins Andrew R
SEC insider (Form 3/4/5 filer). CIK 0001590157. President and CEO at Cogent Biosciences, Inc. (COGT). 6 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in WALTHAM, MA.
Companies Robbins Andrew R has filed insider reports for
- Cogent Biosciences, Inc. (COGT): Director, Officer, President and CEO
Robbins Andrew R
CIK: 0001590157
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cogent Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- May 19, 2026COGT
Cogent Biosciences, Inc.
GiftDirect160K shares- - May 19, 2026COGT
Cogent Biosciences, Inc.
GiftIndirect160K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
AwardDirect185K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
AwardDirect840K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
Tax PaymentDirect367.5K shares at avg. $39.45$14.5M - Jan 23, 2025COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
915K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 | COGT Cogent Biosciences, Inc. | Gift | 160,000 | - | $0 | Direct |
| May 19, 2026 | COGT Cogent Biosciences, Inc. | Gift | 160,000 | - | $0 | Indirect |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award | 185,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award | 840,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Tax Payment | 367,497 | $39.45 | $14,497,757 | Direct |
| Jan 23, 2025 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 915,000 | - | - | Direct |
1-6 of 6 transactions